Β-Thalassemias | NEJM
Cureus | Thalassemia: A Review of the Challenges to the Families and Caregivers
Safety and efficacy of thalidomide in patients with transfusion-dependent β- thalassemia: a randomized clinical trial | Signal Transduction and Targeted Therapy
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
PDF) Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm
Non-transfusion-dependent thalassemias | Haematologica
Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu
IJMS | Free Full-Text | Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
Beta Thalassemia: Practice Essentials, Etiology, Epidemiology
Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)
Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)
Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley
β-Thalassemia | Genetics in Medicine
Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment | Gene Therapy
Frontiers | New Insights Into Pathophysiology of β-Thalassemia
Current and future alternative therapies for beta-thalassemia major - ScienceDirect
Thalassaemia - The Lancet
An urgent need for improving thalassemia care due to the wide gap in current real-life practice and clinical practice guidelines | Scientific Reports
JCM | Free Full-Text | Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?
A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? - ScienceDirect
Gene Therapy For Beta-Thalassemia: Updated Perspectives | TACG
Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
Sirolimus for Treatment of β-Thalassemia: From Pre-Clinical Studies to the Design of Clinical Trials
